Vanuatu Technology Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Technology Update.

Press releases published on July 27, 2026

Jul. 27, 2026

EagleNXT Joint Venture “ThirdEye USA” Selected to Participate in EXTiC 26-2 Counter-UAS Experimentation Event

Indeterminate GlobeNewswire

Jul. 27, 2026

Rezolve Ai Delivers Breakout First-Half Performance: Preliminary H1 2026 Revenue Expected to Reach Approximately $127 Million, Nearly 20x H1 2025

Indeterminate GlobeNewswire

Jul. 27, 2026

Linkage Global Unveils "Human Resonance OS," Advancing Its AI-Enabled Wellness Ecosystem as Next-Generation Healthcare Infrastructure

Indeterminate GlobeNewswire

Jul. 27, 2026

2Checkout Named Best Payments Solution by Industry Peers at the 2026 CODiE Awards

Indeterminate GlobeNewswire

Jul. 27, 2026

XRPPower Launches AI-Powered Trading Platform Focused on Digital Asset Management and Trading Technology

Indeterminate GlobeNewswire

Jul. 27, 2026

Genius Group Offers Share Loyalty Bonus Program Delivering up to 59% Return on Investment in six months, Closing July 31, 2026.

Indeterminate GlobeNewswire

Jul. 27, 2026

Frost & Sullivan Selects Fusemachines as a Strategic Partner for Agentic AI

Indeterminate GlobeNewswire

Jul. 27, 2026

Micron Biomedical Secures $4.5 Million Federal Contract to Develop First Dissolvable Microarray Radiation/Nuclear Medical Countermeasure

Indeterminate GlobeNewswire

Jul. 27, 2026

Quantum Cyber Completes First Mini-Interceptor Drone at Its Newly U.S. Manufacturing Facility in Bridgeport, Connecticut

Indeterminate GlobeNewswire

Jul. 27, 2026

US Defense Manufacturer, Elmet Technologies, to Streamline Supply Chain for Rapid Production of Hypersonic Vehicle Parts with 3D Systems DMP Flex 350 Triple

Indeterminate GlobeNewswire

Jul. 27, 2026

Eikon Therapeutics Announces First Patient Dosed in TeLuRide-008, a Registrational Phase 2/3 Trial of EIK1001 in Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

Jul. 27, 2026

QTREX Launches Quantum Interconnect Research Program with Commercialization Rights to Project-Generated IP

Indeterminate GlobeNewswire

Jul. 27, 2026

Social Security Administration Challenges Drive MoneySimpler to Launch AI Automated Trading Retirement Income Solution

Indeterminate GlobeNewswire

Jul. 27, 2026

VERAXA Biotech Announces Advancement of Novel Bispecific Antibody Drug Conjugate Program VXA-222 from Joint Discovery Collaboration with OmniAb

Indeterminate GlobeNewswire

Jul. 27, 2026

OKYO Pharma to Participate in the BTIG Biotechnology Conference 2026

Indeterminate GlobeNewswire

Jul. 27, 2026

Tonix Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 10, 2026

Indeterminate GlobeNewswire

Jul. 27, 2026

Harrow To Report Second Quarter 2026 Financial Results After Market Close on August 10, 2026

Indeterminate GlobeNewswire

Jul. 27, 2026

Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026

Indeterminate GlobeNewswire

Jul. 27, 2026

CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder

Indeterminate GlobeNewswire

Jul. 27, 2026

MapLight Therapeutics Announces Positive Topline Results from Phase 2 ZEPHYR Trial of ML-007C-MA in Schizophrenia

Indeterminate GlobeNewswire